摘要
目的探讨硫酸镁联合胺碘酮治疗室性心动过速的临床疗效。方法整群选取2014年1月—2015年6月该院收治的室性心动过速患者86例,作为研究对象。采用随机数表法将其分为观察组与对照组,每组患者43例,其中对照组患者单纯接受胺碘酮治疗,观察组在对照组基础上加用硫酸镁治疗,比较两组患者治疗后总有效率及不良反应发生情况。结果观察组治疗总有效率为93.02%,对照组治疗总有效率为81.40%,观察组治疗总有效率明显高于对照组,P<0.05,差异具有统计学意义;观察组发生不良反应4例(9.30%),对照组不良反应发生5例(11.63%),观察组不良反应发生率与对照组比较,差异无统计学意义(P>0.05)。结论采用胺碘酮联合硫酸镁治疗室性心动过速疗效确切,并且患者不良反应发生率较低,应用较为安全可靠,具有临床应用及推广价值。
Objective To discuss the clinical curative effect of epsom salt combined with amiodarone in treatment of ventricular tachycardia. Methods 86 cases of patients with ventricular tachycardia treated in our hospital from January 2014 to June 2015 were selected as the research object and randomly divided into the two groups with 43 cases in each, the control group were given only amiodarone treatment, the observation group were given amiodarone combined with epsom salt treatment, the total effective rate and the adverse reactions after treatment of the two groups were compared. Results The total effective rate in the observation group was obviously higher than that in the control group（93.02% vs 81.40%）P〈0.05, the difference was statistically significant; there were 4 cases with adverse reaction in the observation group and 5 cases with adverse reaction in the control group, and there was not obvious difference in the incidence rate of adverse reaction between the two groups（9.30% vs 11.63%）（P〉 0.05）. Conclusion The curative effect of amiodarone combined with epsom salt in treatment of ventricular tachycardia is definite, the incidence rate of adverse reactions in patients is lower, which is safe and reliable and is worthy of application and promotion in clinic.
出处
《中外医疗》
2016年第1期95-96,共2页
China & Foreign Medical Treatment
关键词
硫酸镁
胺碘酮
室性心动过速
临床疗效
Epsom salt
Amiodarone
Ventricular tachycardia
Clinical curative effect
